Planet 13 Holdings (PLNH) Retained Earnings (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Retained Earnings came in at $371.9 million in Q1 2026, up 0.81% year-on-year from $368.9 million in Q1 2025, and up 216.19% on a QoQ basis from -$320.0 million in Q4 2025.
Planet 13 Holdings (PLNH) Retained Earnings (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Retained Earnings data on file, last reported at $371.9 million in Q1 2026.
- On a quarterly basis, Retained Earnings rose 0.81% year-over-year to $371.9 million in Q1 2026; TTM through Mar 2026 was $371.9 million, a 0.81% increase from a year earlier, with the FY2025 full-year figure at -$320.0 million, down 24.96% from the prior year.
- Retained Earnings for Q1 2026 stood at $371.9 million, up from -$320.0 million in the prior quarter.
- Over the last five years, Retained Earnings for PLNH reached as high as $380.3 million in Q3 2024 and fell as low as -$320.0 million in Q4 2025.
- Historically, Retained Earnings has averaged $124.7 million across 5 years, with a median of $314.0 million in 2023.
- Across the five-year window, Retained Earnings soared 511.81% in 2023 and plunged 182.93% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$134.7 million in 2022, then soared by 334.56% to $316.0 million in 2023, then sank by 181.06% to -$256.1 million in 2024, then retreated by 24.96% to -$320.0 million in 2025, then surged by 216.19% to $371.9 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $371.9 million in Q1 2026, -$320.0 million in Q4 2025, and -$315.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | 371.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 371.85 Mn |
| Dec 31, 2025 | -320.03 Mn |
| Sep 30, 2025 | -315.41 Mn |
| Jun 30, 2025 | 369.38 Mn |
| Mar 31, 2025 | 368.88 Mn |
| Dec 31, 2024 | -256.11 Mn |
| Sep 30, 2024 | 380.34 Mn |
| Jun 30, 2024 | 380.32 Mn |
| Mar 31, 2024 | 325.92 Mn |
| Dec 31, 2023 | 315.95 Mn |
| Sep 30, 2023 | 314.63 Mn |
| Jun 30, 2023 | 314.03 Mn |
| Mar 31, 2023 | -143.18 Mn |
| Dec 31, 2022 | -134.70 Mn |
| Sep 30, 2022 | -82.51 Mn |
| Jun 30, 2022 | -76.25 Mn |
| Mar 31, 2022 | 307.04 Mn |
| Dec 31, 2021 | -75.16 Mn |